Cardioprotective effect of a medicinal mushroom, Ganoderma lucidum against adriamycin induced toxicity

International Journal of Pharmacology

Volumn 8, Issue 4, 2012, Pages 252-258

  Rajasekaran, M ^a   Kalaimagal, C ^a  

^a SASTRA UNIVERSITY   (India)

Author keywords

Adriamycin; Antioxidant; Cardioprotection; Mushroom

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CATALASE; CREATINE KINASE; DOXORUBICIN; GANODERMA LUCIDUM EXTRACT; GLUTATHIONE; GLUTATHIONE PEROXIDASE; GLUTATHIONE TRANSFERASE; LACTATE DEHYDROGENASE; SUPEROXIDE DISMUTASE;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CARDIOTOXICITY; CONTROLLED STUDY; CREATINE KINASE BLOOD LEVEL; HEART PROTECTION; LACTATE DEHYDROGENASE BLOOD LEVEL; LIPID PEROXIDATION; MUSHROOM; NONHUMAN; RAT; TISSUE LEVEL;

EID: 84859059477     PISSN: 18117775     EISSN: 18125700     Source Type: Journal    
DOI: 10.3923/ijp.2012.252.258     Document Type: Article

References (82)

1. Abdel Baky, N.A., A.M. Mohamed and L.M. Faddah, 2009. Protective effect of N-acetyl cysteine and/or pro vitamin a against monosodium glutamate-induced cardiopathy in rats. J. Pharmaco. Toxicol., 4: 178-193.
2. Aleisa, A.M., S.S. Al-Rejaie, S.A. Bakheet, A.M. Al-Bekairi and Q.A. Al-Shabanah et al., 2010. Protective effect of metformin on cardiac and hepatic toxicity induced by adriamycin in Swiss albino mice. Asian J. Biochem., 5: 275-284.
3. Arena, E., R.D. Bionda, N. Alessandro, L. Dusanchet and F. Gerbasi, 1974. DNA, RNA and protein synthesis in heart, liver and brain of mice treated with daunorubicin or adriamycin. Int. Res. Commun. Syst. Med. Sci.,2: 1053-1061
4. Asdaq, S.M.B., M.N. Inamdar, M. Asad and P.K. Nanjundan, 2008. Interaction of propranolol with garlic in isoproterenol induced myocardial infarction in rat. J. Pharmacol. Toxicol., 3: 414-424.
5. Balanehru, S. and B. Nagarajan, 1992. Intervention of adriamycin-induced free radical damage. Biochem. Int., 28: 735-744.
6. Bolaman, Z., C. Cizek, G. Kadikoylu, S. Barulka, M. Serter, C. Yenisey and G. Alper, 2005. The protective effects of amifostine on adriamycin-induced acute cardiotoxicity in rats. Tohoku J. Exp. Med., 207: 249-253.
7. Buja, L.M., V.J. Ferrans, R.J. Meyer, W.C. Roberts and E.S. Henderson, 1973. Cardiac ultrastructural changes induced by daunorubicin therapy. Cancer, 32: 771-778.
8. Burta, O., F. Tirlea, O.L. Burta and S.M. Qadri, 2008. Phytotherapy in cardiovascular diseases: From ethnomedicine to evidence based medicine. J. Biol. Sci., 8: 242-247.
9. Chang, S.T. and J.A. Buswell, 1999. Ganoderma lucidum (Curt.: Fr.) P. Karst. (Aphyllophoromycetideae)-a mushrooming medicinal mushroom. Int. J. Med. Mushrooms, 1: 139-146.
10. Cherian, E., N.P. Sudhesh, K.K. Janardhanan and G. Patani, 2009. Free-radical scavenging and mitochondrial antioxidant activities of Reishi-Ganoderma lucidum (Curt: Fr) P. Karst and Arogyapacha-Trichopus zeylanicus Gaertn extracts. J. Basic Clin. Physiol. Pharmacol, 20: 289-307.
11. Christiansen, S. and R. Autschbach, 2006. Doxorubicin in experimental and clinical heart failure. Eur. J. Cardiothorac. Surg., 30: 611-616.
12. Doroshow, J.H. and KJ. Davies, 1986. Redox cycling of anthracyclines by cardiac mitochondria. II. Formation of superoxide anion, hydrogen peroxide and hydroxyl radical. J. Biol. Chem., 261: 3068-3074.
13. Doroshow, J.H., 1983. Effect of anthracycline antibiotics on oxygen radicals formation in rat heart. Cancer Res., 43: 460-472.
14. Doroshow, J.H., 1983. Anthracycline antibiotic-stimulated superoxide, hydrogen peroxide and hydroxyl radical production by NADH dehydrogenase. Cancer Res., 43: 4543-4551.
15. Doroshow, J.H., 1991. Doxorubicin-induced cardiac toxicity. N. Engl. J. Med., 324: 843-845.
16. Doroshow, J.H., G.Y. Locker and C.E. Myers, 1980. Enzymatic defenses of the mouse heart against reactive oxygen metabolites: Alterations produced by doxorubicin. J. Clin. Invest., 65: 128-135.
17. Elberry, A.A., A.B. Abdel-Naim, E.A. Abdel-Sattar, A.A. Nagy, H.A. Mosli, A.M. Mohamadin and O.M. Ashour, 2010. Cranberry (Vaccinium macrocarpon) protects against doxorubicin-induced cardiotoxicity mrats. Food Chem. Toxicol., 48: 1178-1184.
18. Ellman, G.L., 1959. Tissue sulfhydril groups. Arch. Biochem. Biophys., 82: 70-77.
19. Fard, M.H., S.L. Bodhankar and M. Dikshit, 2008. Cardioprotective activity of fruit of Lagenaria siceraria (Molina) standley on doxorubicin induced cardiotoxicity in rats. Int. J. Pharmacol., 4: 466-471.
20. Farvin, K.H.S., A. Surendraraj and R. Anandan, 2009. Protective effect of squalene on endogenous antioxidant vitamins in experimentally induced myocardial infarction in rats. Asian J. Biochem., 4: 133-139.
21. Gao, Y., S.H. Zhou, G. Chen, X. Dai and J. Ye, 2002. A phase I/II study of a Ganoderma lucidum (Curt.: Fr.) P. Karst. extract (Ganopofy) in patients with advanced cancer. Int. J. Med. Mushrooms, 4: 207-214.
22. Gosalvez, M., G.D.V. Rossum and M.F. Blanco, 1979. Inhibition of sodium-potassium-activated adenosine 5 -triphosphatase and ion transport by adriamycin. Cancer Res., 39: 257-261.
23. Habig, W.H., M.J. Pabst and W.B. Jakoby, 1974. Glutathione-S-transferases. The first enzymatic step in mercapturic acid formation. J. Biol. Chem., 249: 7130-7139.
24. Henderson, I.C. and E. Frei, 1980. Ill: Adriamycin cardiotoxicity. Atmos. Heart J., 99: 671-674.
25. Ibrahim, S.S., M.A. Barakat and H.T.S. Helmy, 2010. Modulating effect of carvedilol on doxorubicin-induced cardiomyopathy and hepatic damage. J. Am. Sci., 6: 20-32.
26. Jackson, J.A., J.P. Reeves, K.H. Muntz, D. Kruk, R.A. Prough, J.T. Willerson and L.M. Buja, 1984. Evaluation of free radical effects and catecholamine alterations in adriamycin cardiotoxicity. Am. J. Pathol, 117: 140-153.
27. Jong, S.C. and J.M. Birmingham, 1992. Medicinal benefits of the mushroom Ganoderma. Adv. Applied Microbiol, 37: 101-134.
28. Joseph, S., B. Sabulal, V. George, T.P. Smina and K.K. Janardhanan, 2009. Antioxidative and antiinflammatory activities of the chloroform extract of Ganoderma lucidum found in South India. Sci. Pharm.,77: 111-121.
29. Kalyanaraman, B., E. Perez-Reyes and R.P. Mason, 1980. Spin-trapping and direct electron spin resonance investigations of the redox metabolism ofquinone anticancer drugs. Biochim. Biophys. Acta., 630: 119-130.
30. Keizer, H.G., H.M. Pinedo, G.J. Schuurhuis and H. Joenje, 1990. Doxorubicin (adriamycin): A critical review of free radical-dependent mechanisms of cytotoxicity. Pharmacol. Ther., 47: 219-231.
31. Khan, M., J.C. Shobha, IK. Mohan, M.U.R. Naidu, C. Sundaram, S. Singh, P. Kuppusamy and V.K. Kutala, 2005. Protective effect of Spirulina against doxorubicin-induced cardiotoxicity. Phytother. Res., 19: 1030-1037.
32. Lee, V., A.K. Randhawa and P.K. Singal, 1991. Adriamycin-induced myocardial dysfunction in vitro is mediated by free radicals. Am. J. Physiol., 261:H989-H995.
33. Lenaz, L. and J.A. Page, 1976. Cardiotoxicity of adriamycin and related anthracyclines. Cancer Treat. Rev., 3: 111-120.
34. Li, T. and P.K. Singal, 2000. Adriamycin-induced early changes in myocardial antioxidant enzymes and their modulation by probucol. Circulation, 102: 2105-2110.
35. Li, T., I. Danelisen, A. Bello-Klem and P.K. Singal, 2000. Effects of probucol on changes of antioxidant enzymes in adriamycin-induced cardiomyopathy in rats. Cardiovasc. Res., 46: 523-532.
36. Liu, F., V.E.C. Ooi and S.T. Chang, 1997. Free radical scavenging activity of mushroom polysaccharide extracts. Life Sci., 60: 763-771.
37. Liu, X., Z. Chen, C.C. Chua, Y.S. Ma, G.A. Youngberg, R. Hamdy and B.H.L. Chua, 2002. Melatonin as an effective protector against doxorubicin-induced cardiotoxicity. Am. J. Physiol., 283: H254-H263.
38. Lown, J.W., H.H. Chen, J.A. Plambeck and E.M. Acton, 1982. Further studies on the generation of reactive oxygen species from activated anthracyclines and the relationship to cytotoxic action and cardiotoxic effects. Biochem. Pharmacol., 31: 575-581.
39. Mason, J.W., 1979. Anthracycline cardiotoxicity: Recognition, management and avoidance. Comp. Ther., 5: 64-68.
40. Mau, J.L., H.C. Lin and S.F. Song, 2002. Antioxidant properties of several specialty mushrooms. Food. Res. Int., 35: 519-526.
41. Mau, J.L., S.Y Tsai, Y.H. Tseng and S.J. Huang, 2005. Antioxidant properties of methanolic extracts from Ganoderma tsugae. Food Chem., 93: 641-649.
42. Misra, H.P. and I. Fridovich, 1972. The role of superoxide anion in the autoxidation of epinephrine and a simple assay for superoxide dismutase. J. Biol. Chem., 247: 3170-3175.
43. Monti, E., E. Prosperi, R. Supino and G. Bottiroli, 1995. Free radical-dependent DNA lesions are involved in the delayed cardiotoxicity induced by adriamycin in the rat. Anticancer Res., 15: 193-197.
44. Myers, C.E., W.P. McGuire, R.H. Liss, I. Ifnm, K. Grotzinger and R.C. Young, 1977. Adriamycin: The role of lipid peroxidation in cardiac toxicity and tumor response. Science, 197: 165-167.
45. Naidu, M., K.V. Kumar, IK. Mohan, C. Sundaram and S. Singh, 2002. Protective effect of Gingko biloba extract against doxorubicin-induced cardiotoxicity in mice. Indian J. Exp. Biol., 40: 894-900.
46. Nandave, M., S.K. Ojha, S. Joshi, S. Kumari and D.S. Arya, 2007. Cardioprotective effect oiBacopa monneira against isoproterenol-induced myocardial necrosis in rats. Int. J. Pharmacol., 3: 385-392.
47. Nowak, D., G. Pierscinski and J. Drzewoski, 1995. Ambroxol inhibits doxorubicin-induced lipid peroxidation in heart of mice. Free. Radic. Biol. Med., 19: 659-663.
48. O'Bryan, R.M., J.K. Luce, R.W. Talley, J.A. Gottlieb, L.H. Baker and G. Bonadonna, 1973. Phase II evaluation of adriamycin in human neoplasia. Cancer, 32: 1-8.
49. Ohkawa, H., N. Ohishi and K. Yagi, 1979. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal. Biochem., 95: 351-358.
50. Ojha, S.K., M. Nandave, S. Arora, R. Narang, A.K. Dinda and D.S. Arya, 2008. Chronic administration of Tribulus terrestris Linn, extract improves cardiac function and attenuates myocardial infarction in rats. Int. J. Pharmacol, 4: 1-10.
51. Onyesom, I., U.E. Uzuegbu, E.K. Nwangwa, G.E. Umukoro and l.R. Aninyei, 2007. Effect of vitamin Eon ethanol-induced increase in some cardiovascular parameters and blood uric acid levels in man. Int. J. Biol. Chem., 1: 156-161.
52. Ozdogan, K., E. Taskyn and N. Dursun, 2011. Protective effect of carnosine on adriamycin-induced oxidative heart damage in rats. Anadolu. Kardiyol. Derg., 1: 3-10.
53. Paglia, D.E. and W.N. Valentine, 1967. Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J. Lab. Clin. Med., 70: 158-169.
54. Pntsos, C.A., M. Sokoloff and D.L. Gustfson, 1992. PZ-51(Ebsuliu) In vivo protection against adriamycin induced mouse cardiac and hepatic lipid peroxidation and toxicity. Biochem. Pharmacol., 44: 839-841.
55. Rajasekaran, M. and C. Kalaimagal, 2011. In vitro antioxidant activity of ethanolic extract of a medicinal mushroom, Ganoderma lucidum. J. Pharm. Sci. Res., 3: 1427-1433.
56. Ramkumar, L., T. Ramanathan, P. Thirunavukkarasu and N. Arivuselvan, 2010. Antioxidant and radical scavenging activity of nine edible mushrooms extract. Int. J. Pharmacol., 6: 950-953.
57. Revis, N.W. and N. Marusic, 1978. Glutathione peroxidase activity and selenium concentration in the hearts of doxorubicin-treated rabbits. J. Mol. Cell. Cardiol., 10: 945-951.
58. Rowan, T. and M.D. Chlebowski, 1979. Adriamycin (doxorubicin) cardiotoxicity: A review. West J. Med., 131: 364-368.
59. Saalu, L.C., G.O. Ajayi, A.A. Adeneye, I.O. Imosemi and A. A. Osinubi, 2009. Ethanol seed extract of graprfruit (Citrus paradisi) as an effective attenuator of doxorubicin-induced oxidative stress in the rat heart. Int. J. Cancer Res., 5: 44-52.
60. Shah, S., M.M. Mohan, S. Kasture, C. Sanna and A. Maxia, 2009. Protective effect of Ephedra nebrodensis on doxorubicin-induced cardiotoxicity in rats. Iranian J. Pharmacol. Therapeutics., 8: 61-66.
61. Shakir, D.K. and K.I. Rasul, 2009. Chemotherapy induced cardiomyopathy: Pathogenesis, monitoring and management. J. Clin. Med. Res., 1: 8-12.
62. Shanmugarajan, T.S., M. Arunsundar, I. Somasundaram, E. Krishnakumar, D. Sivaraman and V. Ravichandiran, 2008. Cardioprotective effect oiFicus hispida Linn. on cyclophosphamide provoked oxidative myocardial injury inaratmodel. Int. J. Pharmacol., 4: 78-87.
63. Shimpo, K., T. Nagatsu, K. Yamoda, T. Sato, H. Niimi and M. Shamato et al., 1991. Ascorbic acid and adriamycin toxicity. Amer. J. Clin. Nutr., 54: 1298S-1301S.
64. Smgal, P.K., C.M.R. Deally and L.E. Weinberg, 1987. Subcellular effects of adriamycin in the heart a concise review. J. Mol. Cell. Cardiol., 19: 817-828.
65. Smgal, P.K., R.J. Segstro, R.P. Singh and M.J. Kutryk, 1985. Changes in lysosomal morphology and enzyme activities during the development of adriamycin-induced cardiomyopathy. Can. J. Cardiol., 1: 139-147.
66. Siveski-Iliskovic, N., M. Hill, D.A. Chow and P.K. Singal, 1995. Probucol protects against adriamycin cardiomyopathy without interfering with its antitumor effect. Circulation, 91: 10-15.
67. Siveski-Iliskovic, N, N. Kaul and P.K. Singal, 1994. Probucol promotes endogenous antioxidants and provides protection against adriamycin-induced cardiomyopathy in rats. Circulation, 89: 2829-2835.
68. Sun, J., H. He and B.J. Xie, 2004. Novel antioxidant peptides from fermented mushroom Ganoderma lucidum. J. Agric. Food. Chem., 52: 6646-6652.
69. Takahara, S., B.H. Hamilton, J.V. Nell, Y. Ogura and E.T. Nishimura, 1960. Hypocatalasemia, a new genetic carrier state. J. Clin. Invest., 29: 610-619.
70. Tan, C, E. Etcubanas, N. Wollner, G. Rosen and A. Gilladoga et al., 1973. Adriamycin-an antitumor antibiotic in the treatment of neoplastic diseases. Cancer, 32: 9-17.
71. Upaganlawar, A. and R. Balaraman, 2010. Protective effects oihagenaria siceraria (Molina) fruit juice in isoproterenol induced myocardial infarction. Int. J. Pharmacol., 6: 645-651.
72. Upaganlawar, A., H. Gandhi and R. Balaraman, 2011. Isoproterenol induced myocardial infarction: Protective role of natural products. J. Pharmacol. Toxicol., 6: 1-17.
73. Vibha, L., S.M.B. Asdaq, S. Nagpal and RK. Rami, 2011. Protective effect of medicinal garlic against isoprenaline induced myocardial infarction in rats. Int. J. Pharmacol, 7: 510-515.
74. Von Hoff, D.D., M.W. Layard, P. Basa, H.L. Davis Jr., A.L. Von Hoff, M. Rozencweig and F.M. Muggia, 1979. Risk factors for doxorubicin-induced congestive heart failure. Ann. Intern. Med., 91: 710-717.
75. Wachtel, G.S., B. Tomhnson and IF. Benzie, 2004. Ganoderma lucidum (Lingzhi), a Chinese medicinal mushroom: Biomarker responses in a controlled human supplementation study. Br. J. Nutr., 91: 263-269.
76. Wasser, S.P. and A.L. Weis, 1999. Medicinal properties of substances occurring in higher basidiomycete mushrooms: Current perspective. Int. J. Med. Mushrooms, 1: 31-62.
77. Wasser, S.P. and A.L. Weis, 1997. Medicinal Mushrooms. In: Ganoderma lucidum, (Curtis: Fr.), Karst, P., E. Nevo, (Eds.). Peledfus Publishing House, Haifa, Israel, pp: 39-39.
78. Wasser, S.P., 2002. Medicinal mushrooms as a source of antitumor and immunomodulating polysaccharides. Applied Microbiol. Biotechnol., 60: 258-274.
79. Wong, K.L., H.H. Chao, P. Chan, L.P. Chang and C.F. Liu, 2004. Antioxidant activity of Ganoderma lucidum in acute ethanol-induced heart toxicity. Phytotherapy Res., 18: 1024-1026.
80. Xu, M.F., P.L. Tang, Z.M. Qian and M. Ashraf, 2001. Effects by doxorubicin on the myocardium are mediated by oxygen free radicals. Life Sci., 68: 889-901.
81. Yoda, Y., M. Nagatzava, T. Abe and Z. Kawakomi, 1986. Prevention of doxorubicin myocardial toxicity in mice by reduced glutathione. Cancer Res., 46: 2551-2556.
82. You, J.S., T.L. Pan and Y.C. Hou, 2006. Schisandra chinensis protects against adriamycin-induced cardiotoxicity in rats. Chang Gung Med. J., 39: 63-70.